Strategic partnerships SRI’s recent collaborations with Mayo Clinic, the University of Florida, Tokyu Land Corporation, and CTI Clinical Research Services indicate strong appetite for joint ventures and pilot programs. This presents sales opportunities in AI, healthcare workflow solutions, global startup initiatives, and contract research services.

AI and sensors Active development of ARPA-H funded AI systems and precision quantum sensors for biomedical diagnostics and defense signals a need for advanced analytics, data integration, and sensor integration capabilities. Position offerings around AI enablement, data visualization, and hardware-software co-design.

Cloud and data SRI employs Microsoft Azure, Dynamics, Tableau, and Splunk, suggesting a readiness for cloud, data analytics, and enterprise workflow solutions. Opportunities exist to expand cloud governance, analytics maturity, integration with Dynamics 365, and security logging.

Healthcare focus Partnerships with Mayo Clinic and CTI, plus biomedical diagnostics work, indicate target verticals in clinical operations and research. Prospects include clinical trial data platforms, regulated data management, and workflow automation for healthcare procedures.

Growth signals Active expansion activities and ARPA-H engagement imply evolving capabilities and potential scaling needs. Sales plays can emphasize scalable infrastructure, partner ecosystems, and flexible services to support rapid growth and diversified programs.